A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients

Written by patrippon on May 14, 2020.

05/14/20

6:30 pm - 8:00 pm

Virtual discusssion on A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients

Speaker:
Sachin Gupta MD
Oncologist/Hematologist
California Cancer Associates for Research & Excellence (cCARE)

Virtual Meeting Info: